Through the INSIDE PHARMA newsletter on Substack and selected publications, Hedley examines outsourcing models, CDMO consolidation, drug shortages, and the strategic redesign of biopharma value‑chains.
We never forget that innovation in biopharmaceuticals, such as advanced therapies, precision medicine, and additive manufacturing, will require advanced skills and knowledge from those wishing to pursue the opportunities and challenges – we can help you get there.
The name on the box is rarely the whole story. Here is how a tablet gets from raw chemicals to your pharmacy shelf, and...
The decisions that cause medicine shortages are made years before anyone runs short.
Shortages rarely have just one possible cause.
Time to spread the word - medicines must be developed, like any other physical Product!
It took 15 years to get penicillin to market -
Jumping is cheaper and the audience goes home after the inspection
Advising pharma, biotech, CDMOs, cold‑chain and logistics leaders — and their legal counsel — across the UK, EU, and US
